Incidence of Intraoperative Awareness in Indian Patient Population

December 9, 2023 updated by: Nitin Sethi, DNB, Sir Ganga Ram Hospital

Impact of Bi-spectral Index Guided Inhalation Anaesthesia on the Incidence of Intraoperative Awareness in Indian Patient Population: A Prospective, Randomised, Multi-Centric Study

The profiling of bi-spectral index (BIS) monitored facilitation of general anesthesia (GA), including, anesthesia induction and maintenance of GA depth state, emergence characteristics, and postoperative recovery parameters, is now extensively available. However, majority of the data supporting the use of BIS have emanated from western Caucasian patient population. Though research on BIS monitoring have also emerged from Asian subcontinent, the data generated, at the best, is too scattered, random, and non-homogenous to reflect onto how BIS guidance fares in Asians on a population basis. We aim to undertake a multi-centric prospective cohort trial in Asian patient population to analyze as to whether BIS guidance toes the profiling and the evidence in Caucasians.

Study Overview

Detailed Description

After Institutional Ethics Committee approval and informed written patient consent, 2000 patients justifying inclusion and exclusion criteria ( will be included in this National, multi-centric, prospective, randomised, double-blind (patients, analyst), 2- arm trial.

All the patients scheduled for elective surgery under general anaesthesia will be randomly (simple computer generated random number table) allocated to one of the following two groups:

Group I [BIS Guided Group, n=1000]: GA will be monitored and controlled with Bi-spectral index (BIS).

Group II [ETAG Guided Group, n=1000]: GA will be monitored and controlled with end-tidal anaesthesia gas concentration (ETAG).

Sample Size Estimation To detect a difference in incidence of awareness of 0.04 % (a rate based on Mashour et al, Anesthesiology 2012) between the ETAG and BIS-guided group a total of 1800 patients will be required at a power of 80% with a type-II error 0f 0.5. To compensate for possible drop outs 10% additional patients will be recruited for the study. Therefore, the total sample size will include 2000 patients.

Randomization concealment: will be done using opaque sealed envelopes with alphabetic codes. In addition, before opening the envelope patient's data slip will be pasted on the envelopes.

Blinding: Investigator, assessor and the data analyst will be blinded to the method of GA (BIS or ETAG guided) Subgroup Analysis: Subgroup analysis will be specifically performed and reported if the data shows gender equivalence (i.e., at least 40% patients of either sex in each group).

Anaesthesia Technique:

Routine monitoring (EtCO2, pulse oximetery, EKG, NIBP) will be applied during the procedure. Anaesthesia will be induced with fentanyl 2-mcg/kg and propofol 1.5-2.5 mg/kg. Non-depolarizing muscle relaxant (vecuronium/ rocuronium/ atracurium) will be administered to facilitate tracheal intubation. GA will be maintained with inhalation regimen (sevoflurane/desflurane-oxygen-air mixture) to target age-related MAC range of 0.7 to 1.3. Corresponding BIS score and end-tidal agent concentration will be noted at 5-minute interval. While, in the BIS group the anaesthesiologist will be blinded to ETAG and MAC readings, in the ETAG group BIS display will be turned off. However, ETAG and MAC data will both be analyzed once the study is over. Although, the MAC will be titrated to haemodynamic goals (+20% baseline of SBP/MAP/Heart rate), it will be maintained within the prescribed range. On either side of the range of MAC, the haemodynamic depression/ activation will be responded to with vasopressor/vasodilators. At the end of surgery inhalation agent delivery will be stopped. The residual neuromuscular blockade will be reversed with neostigmine and glycopyrrolate.

The patients will be extubated once wide-awake and following commands. ASSESSMENT PARAMETERS Analysis of Intraoperative Awareness Quantitative: The participants will be subjected to modified Brice Interview 20 24-hours after surgery and after one month. The Brice interview at one month will be undertaken through telephonic contact and if awareness is present on any or both the occasions, a three-member independent awareness committee will review the incidence intensively. The awareness will be adjudicated in broad divisions, including, definite, possible, and no awareness. 21 No Awareness: No awareness or a perception of awareness that has a high probability of occurrence in the preoperative and the postoperative period.

Possible Awareness: There is a perception of awareness but the patient is unable to recall any event definitive indicative of awareness.

Definite Awareness: Perception of awareness that has clear recall or has a high likelihood of occurring in the intraoperative period.

Qualitative: After adjudication of a definite awareness by the awareness committee, the participants will be classified on the awareness pattern using the Michigan awareness classification instrument. 21 Class 1 will be defined by isolated auditory perception, Class 2 by tactile perceptions, Class 3 by pain experience, Class 4 by a feeling of paralysis and helplessness to move, and Class 5 by the presence of both paralysis and pain. If the awareness event is associated with distress the class will be modified with a suffix "D".

If definite awareness is present, the participants will be offered counselling sessions to ward off long-term behavioral changes and post-traumatic stress disorder (PTSD) The inter-reviewer observation will be analyzed for agreement using Fleiss's Kappa statistics for blinded assessment.

BIS score and end-tidal inhalation agent concentration: The intraoperative BIS scores and end-tidal inhalation agent concentration will be noted (every 5-minutes).

Time to awakening and tracheal extubation: Time (in minutes) to awakening will be noted after discontinuation of anaesthesia to point of first spontaneous eye opening. The time will be confirmed by the ability of the patient to obey commands. Time (in minutes) to tracheal extubation will comprise of the period after discontinuation of anaesthesia to tracheal extubation.

Statistical Analysis:

Demographic and procedural data will be analyzed with student's t-test, double sided, or the Chi-square test with Yate's correction as appropriate. Analysis of awareness outcome will be performed using Fisher's exact test. Sensitivity and specificity analysis will be undertaken for BIS values vis-à-vis explicit recall or no recall.

Study Type

Interventional

Enrollment (Estimated)

2000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Chandigarh, India
        • Post Graduate Institute For Medical Education & Research
      • Kolkata, India, 700054
        • Apollo Gleneagles Hospital
      • Mumbai, India
        • P D Hinduja Hospital & Medical Research Centre
    • Delhi
      • New Delhi, Delhi, India, 110060
        • Sir Ganga Ram Hospital
    • Tamil Nadu
      • Chennai, Tamil Nadu, India, 600002
        • Prof. L Parthasarathy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 63 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male or female gender
  • Aged 18-65 yrs.
  • ASA Physical Status I/II
  • General Anaesthesia
  • Elective Surgery
  • Surgery duration > 30-minutes
  • Consenting for follow-up

Exclusion Criteria:

  • Uncompensated systemic co-morbidity
  • Cardiac and Neurosurgical procedures
  • Head & Neck surgery
  • Obstetric surgery
  • Emergency surgery
  • Anticipated difficult airway
  • H/O brain injury, EEG abnormality
  • Neuropsychiatry disorders
  • Substance abuse (opioids, alcohol, recreational drugs, benzodiazepine)
  • Pacemakers & Electronic implants
  • Obesity (BMI>30kg/m2)
  • Adhesive allergy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: BIS Guided Group
GA will be monitored and controlled with Bi-spectral index (BIS) monitoring.The anaesthesiologist will be blinded to ETAG and MAC readings.
GA will be monitored and controlled with Bi-spectral index (BIS).
Active Comparator: ETAG Guided Group
GA will be monitored and controlled with end-tidal anaesthesia gas (ETAG) monitoring.The anaesthesiologist will be blinded to the BIS readings.
GA will be monitored and controlled with end-tidal anaesthesia gas concentration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of intraoperative awareness
Time Frame: From end of anaesthesia till 30-days postoperatively
Will be assessed using Modified Brice Interview and Michigan awareness classification instrument
From end of anaesthesia till 30-days postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative Bi-spectral index (BIS) score
Time Frame: From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively
BIS values will be recorded from the patient monitor
From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively
Intraoperative End-tidal anaesthesia gas (ETAG) concentration
Time Frame: From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively
ETAG concentration will be recorded from the patient monitor
From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively
Intraoperative minimum alveolar concentration (MAC)
Time Frame: From beginning of anesthesia (0-hours, baseline) till 8 hours intraoperatively
MAC will be recorded from the patient monitor
From beginning of anesthesia (0-hours, baseline) till 8 hours intraoperatively
Recovery from anaesthesia
Time Frame: From end of anaesthesia till 20-minutes postoperatively
Time taken by the patient to open his/her eyes after discontinuation of anaesthesia will be noted
From end of anaesthesia till 20-minutes postoperatively
Recovery from anaesthesia
Time Frame: From end of anaesthesia till 20-minutes postoperatively
Time taken for tracheal extubation after discontinuation of anaesthesia will be noted
From end of anaesthesia till 20-minutes postoperatively
Changes in intra-operative heart rate (beats per minute)
Time Frame: From beginning of anesthesia (0-hours, baseline) till 8 hours intra-operatively
Comparison of intra-operative heart rate between both the arms will be done
From beginning of anesthesia (0-hours, baseline) till 8 hours intra-operatively
Change in Intra-operative blood pressure - systolic , diastolic, and mean (mmHg)
Time Frame: From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively]
Comparison of intra-operative blood pressure- systolic, diastolic, and mean between both the arms will be done
From beginning of anaesthesia (0-hours, baseline) till 8 hours intraoperatively]
Postoperative Sedation
Time Frame: From end of anaesthesia till 24-hours postoperatively]
Will be assessed using Modified Observer's assessment of alertness/sedation scale (OASS). This scale measures postoperative sedation on a scale of 0 to 5. A score of '0' indicates patient is deeply sedated with no response to any stimuli , whereas a score of 5 indicates that the patient is wide awake.
From end of anaesthesia till 24-hours postoperatively]
Postoperative Nausea and Vomiting (PONV)
Time Frame: From end of anaesthesia till 24-hours postoperatively]
Will be assessed using postoperative nausea and vomiting (PONV) Scale. The scale measures PONV on a scale of 0 to 2. A score of '0' indicates that the patient has no emetic symptoms, whereas a score of '2' indicates that the patient has vomiting.
From end of anaesthesia till 24-hours postoperatively]
Postoperative Analgesia
Time Frame: From end of anaesthesia till 24-hours postoperatively
Will be assessed using 10-point Visual Analogue Scale (VAS) Score which measures pain on a scale of 0 to 10. A score of '0' indicates that the patient is free of pain whereas a score of '10' indicates that patient has severe pain.
From end of anaesthesia till 24-hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Amitabh Dutta, MD, PhD, Sir Ganga Ram Hospital
  • Principal Investigator: Nitin Sethi, DNB, Sir Ganga Ram Hospital
  • Study Director: Jayashree Sood, MD,FFRCA, Sir Ganga Ram Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2018

Primary Completion (Estimated)

March 2, 2025

Study Completion (Estimated)

March 2, 2025

Study Registration Dates

First Submitted

June 19, 2018

First Submitted That Met QC Criteria

June 19, 2018

First Posted (Actual)

June 28, 2018

Study Record Updates

Last Update Posted (Estimated)

December 12, 2023

Last Update Submitted That Met QC Criteria

December 9, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraoperative Awareness

3
Subscribe